Amicus Therapeutics Inc (FOLD) — Cash Flow Reinvestment Rate
Amicus Therapeutics Inc (FOLD) has a Cash Flow Reinvestment Rate of 0.40x as of December 2025, reinvesting $6.49 Million (capex $299.00K plus investments $-6.20 Million) from operating cash flow of $16.25 Million. Explore how much does Amicus Therapeutics Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amicus Therapeutics Inc Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Amicus Therapeutics Inc across 2 annual periods. Also explore FOLD total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Amicus Therapeutics Inc (2007–2025)
Year-by-year capital reinvestment analysis for Amicus Therapeutics Inc. For live market cap and broader valuation context, see market cap of Amicus Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | $46.43 Million | $33.15 Million | $3.30 Million | ▲ +3081.2% |
| 2007 | 0.04x | $669.00K | $15.19 Million | $669.00K | — |